Pharmacokinetic models for FcRn-mediated IgG disposition

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Xiao, Jim J ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FC RECEPTOR; IMMUNOGLOBULIN G; FC RECEPTOR, NEONATAL; HLA ANTIGEN CLASS 1;

BINDING AFFINITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG MEGADOSE; DRUG RECEPTOR BINDING; MODEL; NONHUMAN; PINOCYTOSIS; REVIEW; SINGLE DRUG DOSE; ANIMAL; BIOLOGICAL MODEL; HUMAN; METABOLISM; PHARMACOKINETICS;

ANIMALS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOGLOBULIN G; MODELS, BIOLOGICAL; PHARMACOKINETICS; RECEPTORS, FC;

EID: 84862294892     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/282989     Document Type: Review

References (34)

1. Brambell F. W. R., Hemmings W. A., Morris I. G., A theoretical model of -globulin catabolism Nature 1964 203 4952 1352 1355
2. Brambell F. W., The transmission of immunity from mother to young and the catabolism of immunoglobulins. The Lancet 1966 2 7473 1087 1093
3. Waldmann T. A., Strober W., Metabolism of immunoglobulins Progress in Allergy 1969 13 1 110
4. Junghans R. P., Anderson C. L., The protection receptor for IgG catabolism is the 2-microglobulin-containing neonatal intestinal transport receptor Proceedings of the National Academy of Sciences of the United States of America 1996 93 11 5512 5516
5. Borvak J., Richardson J., Medesan C., Antohe F., Radu C., Simionescu M., Ghetie V., Ward E. S., Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice International Immunology 1998 10 9 1289 1298 (Pubitemid 28414334)
6. Ghetie V., Hubbard J. G., Kim J. K., Tsen M. F., Lee Y., Ward E. S., Abnormally short serum half-lives of IgG in 2-microglobulin-deficient mice European Journal of Immunology 1996 26 3 690 696 (Pubitemid 26091401)
7. Campbell R. M., Cuthbertson D. P., Matthews C. M., McFarlane A. S., Behaviour of 14C- and 131I-labelled plasma proteins in the rat The International Journal of Applied Radiation and Isotopes 1956 1 1-2 66 84
8. McFarlane A. S., The behavior of I 131-labeled plasma proteins in vivo Annals of the New York Academy of Sciences 1957 70 1 19 25
9. Ramalingam T. S., Detmer S. A., Martin W. L., Bjorkman P. J., IgG transcytosis and recycling by FcRn expressed in MDCK cells reveals ligand-induced redistribution The EMBO Journal 2002 21 4 590 601 (Pubitemid 34174040)
10. Israel E. J., Wilsker D. F., Hayes K. C., Schoenfeld D., Simister N. E., Increased clearance of IgG in mice that lack 2-microglobulin: possible protective role of FcRn Immunology 1996 89 4 573 578 (Pubitemid 26419660)
11. Wochner R. D., Drews G., Strober W., Waldmann T. A., Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. The Journal of Clinical Investigation 1966 45 3 321 329
12. Waldmann T. A., Terru W. D., Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin The Journal of Clinical Investigation 1990 86 6 2093 2098
13. Kim J., Hayton W. L., Robinson J. M., Anderson C. L., Kinetics of FcRn-mediated recycling of IgG and albumin in human: pathophysiology and therapeutic implications using a simplified mechanism-based model Clinical Immunology 2007 122 2 146 155 (Pubitemid 46073892)
14. Gurbaxani B., Mathematical modeling as accounting: predicting the fate of serum proteins and therapeutic monoclonal antibodies Clinical Immunology 2007 122 2 121 124 (Pubitemid 46091771)
15. Imbach P., Barandun S., d'Apuzzo V., High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood The Lancet 1981 1 8232 1228 1231
16. Deng R., Balthasar J. P., Pharmacokinetic/pharmacodynamic modeling of IVIG effects in a murine model of immune thrombocytopenia Journal of Pharmaceutical Sciences 2007 96 6 1625 1637 (Pubitemid 46953777)
17. Hansen R. J., Balthasar J. P., Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura Journal of Pharmacology and Experimental Therapeutics 2001 298 1 165 171 (Pubitemid 32574523)
18. Jin F., Balthasar J. P., Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura Human Immunology 2005 66 4 403 410 (Pubitemid 40615796)
19. Xiao J. J., Krzyzanski W., Wang Y. M., Li H., Rose M. J., Ma M., Wu Y., Hinkle B., Perez-Ruixo J. J., Pharmacokinetics of anti-hepcidin monoclonal antibody Ab 12B9m and hepcidin in cynomolgus monkeys AAPS Journal 2010 12 4 646 657
20. Ferl G. Z., Wu A. M., DiStefano J. J., A predictive model of therapeutic monoclonal antibody dynamics and regulation by the neonatal Fc receptor (FcRn) Annals of Biomedical Engineering 2005 33 11 1640 1652 (Pubitemid 41801648)
21. Garg A., Balthasar J. P., Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice Journal of Pharmacokinetics and Pharmacodynamics 2007 34 5 687 709 (Pubitemid 47477039)
22. Urva S. R., Yang V. C., Balthasar J. P., Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody Journal of Pharmaceutical Sciences 2010 99 3 1582 1600
23. Davda J. P., Jain M., Batra S. K., Gwilt P. R., Robinson D. H., A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs International Immunopharmacology 2008 8 3 401 413 (Pubitemid 351221431)
24. Hansen R. J., Balthasar J. P., Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia Journal of Pharmaceutical Sciences 2003 92 6 1206 1215 (Pubitemid 36676467)
25. Hansen R. J., Balthasar J. P., Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia Blood 2002 100 6 2087 2093 (Pubitemid 35001242)
26. Hopkins C. R., Trowbridge I. S., Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells Journal of Cell Biology 1983 97 2 508 521 (Pubitemid 13041016)
27. Ober R. J., Martinez C., Vaccaro C., Zhou J., Ward E. S., Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn Journal of Immunology 2004 172 4 2021 2029 (Pubitemid 38182347)
28. Bleeker W. K., Teeling J. L., Erik Hack C., Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect Blood 2001 98 10 3136 3142
29. Davies B., Morris T., Physiological parameters in laboratory animals and humans Pharmaceutical Research 1993 10 7 1093 1095 (Pubitemid 23211439)
30. Cure S. F., Cremer N. E., Decreased rate of synthesis of immunoglobulin (IgG) in rats infected with moloney leukemia virus. Journal of Immunology 1969 102 6 1345 1353
31. Ghetie V., Popov S., Borvak J., Radu C., Matesoi D., Medesan C., Ober R. J., Ward E. S., Increasing the serum persistence of an IgG fragment by random mutagenesis Nature Biotechnology 1997 15 7 637 640 (Pubitemid 27291163)
32. Hinton P. R., Johlfs M. G., Xiong J. M., Hanestad K., Ong K. C., Bullock C., Keller S., Tang M. T., Tso J. Y., Vsquez M., Tsurushita N., Engineered human IgG antibodies with longer serum half-lives in primates The Journal of Biological Chemistry 2004 279 8 6213 6216 (Pubitemid 38248752)
33. Gurbaxani B., Dela Cruz L. L., Chintalacharuvu K., Morrison S. L., Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life Molecular Immunology 2006 43 9 1462 1473 (Pubitemid 43356386)
34. Junghans R. P., IgG biosynthesis: no immunoregulatory feedback Blood 1997 90 10 3815 3818